Friday, September 30, 2022


Biotechnology News Magazine

GT Molecular Launches Highly Sensitive PCR-based Tests for UK, South African, and Brazilian/Japanese Variants of Concern

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

April 14, 2021

GT Molecular, a leader in wastewater-based epidemiological testing, has reported the detection of mutational profiles of the South African, Brazilian/Japanese, and UK variants in several wastewater treatment plants around the United States.

This is an additional piece of evidence that these variants of concern are spreading in the United States.

Product offerings:


Designed for


1.   Nationwide Fee-for-service testing of wastewater samples for UK, South African, and Brazilian/Japanese Variants of SARS-CoV-2

Communities, wastewater treatment operations, Researchers, Health officials


2.   SARS-CoV-2 Multivariant Discrimination Assay Commercial Reagent Kit for both RT-PCR and digital PCR instruments.

Research labs doing their own community testing, environmental testing labs, CLIA labs, Health officials


“GT Molecular is the laboratory muscle behind our [SARS-CoV-2 Predictive] model,” said Frank Martz, City Manager for the City of Altamonte Springs, Florida. “As mutations and variants gained traction, GT Molecular created new tools producing highly accurate, well-reported and timely variant data to our City, which has been shared throughout decision-makers in Florida. GT Molecular’s data has been validated by our state’s lab as accurate and reliable. GT Molecular’s ability to accurately identify and report variant prevalence before people produce symptoms has been an indispensable tool helping to better protect citizens in our region.”

“We have appreciated greatly the accurate results and consistently quick turn-around time GT Molecular provides, and the ability to evaluate the presence in our community of mutations associated with certain variants has helped us clearly communicate changing risks in our different neighborhoods as well as support our State’s genomic sequencing efforts,” said Brian Lowe, Chief Innovation Officer and COVID-19 Response Leader for the City of Burlington, VT. “The timely data regarding viral prevalence over the past months has enabled us to shift testing and tracing resources to areas that need them most in our community, and the ability of GT Molecular’s leadership to discuss with us the trends, implications, and unknowns has helped our community respond quickly to the changing nature of the pandemic.”

The underlying, patent pending, technology that allows GT Molecular to track these variants in wastewater is available for sale as All-in-One commercial reagent kits providing laboratories with high quality, pre-validated reagents and controls so they can continue to serve their communities with high confidence and no lost time. “We have been using the digital PCR 4-plex (Wuhan + B.1.1.7) differentiation wastewater test kit for wastewater surveillance across the city of Houston. It has allowed us to track the emergence of the B.1.1.7 variant in a rapid, easy-to-use assay.” says Dr. Lauren Stadler, Assistant Professor at Rice University.


Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine